Maternal immunization.

B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50

New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med (2010) 1.38

Neonatal sepsis and neutrophil insufficiencies. Int Rev Immunol (2010) 0.96

Pertussis antibodies in postpartum women and their newborns. J Perinatol (2009) 0.86

Treatment of neonatal infections: a multi-country analysis of health system bottlenecks and potential solutions. BMC Pregnancy Childbirth (2015) 0.83

Pertussis vaccination in pregnancy. Hum Vaccin Immunother (2016) 0.78

Development of serum antibodies during early infancy in rhesus macaques: implications for humoral immune responses to vaccination at birth. Vaccine (2014) 0.76

The safety of maternal immunization. Hum Vaccin Immunother (2016) 0.75

Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis. PLoS One (2017) 0.75

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis (2012) 2.96

Group B streptococcal infections in elderly adults. Clin Infect Dis (2005) 2.59

Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics (2008) 2.45

Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 2.20

Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis (2010) 2.09

Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis (2004) 1.96

Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis (2011) 1.85

Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis (2004) 1.73

Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin Infect Dis (2001) 1.66

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis (2009) 1.64

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics (2010) 1.59

Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol (2004) 1.53

Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis (2004) 1.48

Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol (2003) 1.42

Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J (2015) 1.39

Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr (2005) 1.31

Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. Clin Infect Dis (2005) 1.24

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23

Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2009) 1.22

Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J (2010) 1.20

Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics (2011) 1.15

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J (2010) 1.15

Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis (2004) 1.14

Features of invasive staphylococcal disease in neonates. Pediatrics (2004) 1.13

Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis (2011) 1.10

Improved methods for typing nontypeable isolates of group B streptococci. Int J Med Microbiol (2002) 1.09

Determinants of co-colonization with group B streptococcus among heterosexual college couples. Epidemiology (2002) 1.08

Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun (2002) 1.08

Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis (2006) 1.06

DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol (2005) 1.03

Long-term outcomes of group B streptococcal meningitis. Pediatrics (2012) 1.01

Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J (2003) 1.01

Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children. J Clin Pharmacol (2003) 1.00

Pertussis immunization in a high-risk postpartum population. Vaccine (2009) 0.96

Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis (2012) 0.95

Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis (2002) 0.92

Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis (2004) 0.88

Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine (2012) 0.86

The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis (2006) 0.86

Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans. J Infect Dis (2006) 0.84

Thoracic actinomycosis in children: case report and review of the literature. Pediatr Infect Dis J (2008) 0.84

Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis (2002) 0.84

Bilateral lung abscesses in an adolescent. Semin Pediatr Infect Dis (2002) 0.83

Fluconazole prophylaxis in the neonatal intensive care unit. Pediatr Infect Dis J (2009) 0.82

An unusual cause of appendicitis in a child. Semin Pediatr Infect Dis (2006) 0.81

Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine (2010) 0.81

Infant pertussis: what to do next? Clin Infect Dis (2011) 0.81

Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine (2007) 0.80

Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc (2004) 0.79

Advances in antifungal therapy. Pediatr Infect Dis J (2005) 0.79

Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J (2004) 0.78

The future of meningococcal vaccines. Pediatr Infect Dis J (2005) 0.78

G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States. Emerg Infect Dis (2015) 0.77

Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis (2006) 0.77

Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. Pediatr Infect Dis J (2004) 0.77

Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine (2009) 0.77

Group B Streptococcal Colonization Among Pregnant Women in Delhi, India. Pediatr Infect Dis J (2016) 0.77

New recommendations for prevention of early-onset group B streptococcal disease in newborns. Pediatr Rev (2003) 0.76

Reply to Leuridan et al. Clin Infect Dis (2013) 0.75

Another success for hepatitis A vaccine. N Engl J Med (2007) 0.75

Importance of influenza vaccination for children. Am Fam Physician (2007) 0.75

Immune Responses to Invasive Group B Streptococcal Disease in Adults. Emerg Infect Dis (2016) 0.75

Practice what we teach. The case for influenza vaccination among school nurses. NASN Sch Nurse (2009) 0.75

Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J (2010) 0.75

Prevalence and Capsular Types of Group B Streptococci Colonizing Indian Women Living in the United States. Pediatr Infect Dis J (2017) 0.75

Vaccinator-in-chief: Houston physician Becomes chair of ACIP. Tex Med (2010) 0.75

Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci. Curr Microbiol (2014) 0.75

Cluster of Bacillus species bacteremia cases in neonates during a hospital construction project. Infect Control Hosp Epidemiol (2011) 0.75